ExLibris header image
SFX Logo
Title: Persistent behavior at high rates maintained by intravenous self-administration of nicotine
Source:

Science [0036-8075] Goldberg, S R yr:1981


Collapse list of basic services Basic
Sorry, no full text available...
Please use the document delivery service (see below)  
Holding information
Holdings in library search engine ALBERT GO
Document delivery
Request document via Library/Bibliothek GO
Users interested in this article also expressed an interest in the following:
1. Goldberg, Lewis R. "An alternative 'description of personality': The Big-Five factor structure." Journal of personality and social psychology 59.6 (1990): 1216-1229. Link to SFX for this item
2. London, S D. "Potential adverse effects of amphetamine treatment on brain and behavior: a review." Molecular psychiatry 14.2 (2008): 123-142. Link to Full Text for this item Link to SFX for this item
3. Spealman, R D D. "Maintenance of schedule-controlled behavior by intravenous injections of nicotine in squirrel monkeys." The Journal of pharmacology and experimental therapeutics 223.2 (1982): 402-408. Link to SFX for this item
4. Cohen, D. "Cigarette smoking and chewing gum: Response to a laboratory-induced stressor." Health psychology 20.5 (2001): 361-368. Link to SFX for this item
5. Foll, B. "Nicotine as a typical drug of abuse in experimental animals and humans." Psychopharmacology 184.3-4 (2006): 367-381. Link to SFX for this item
6. Digman, John M. "Personality Structure: Emergence of the Five-Factor Model." Annual review of psychology 41.1 (1990): 417-440. Link to Full Text for this item Link to SFX for this item
7. Goldberg, Lewis R., Lewis R. "The Development of Markers for the Big-Five Factor Structure." Psychological assessment v4.n1 (1992): 26-42. Link to SFX for this item
8. Goldberg, R. "The structure of phenotypic personality traits." The American psychologist 48.1 (1993): 26-34. Link to SFX for this item
9. McCrae, Robert R. "Validation of the five-factor model of personality across instruments and observers." Journal of personality and social psychology 52.1 (1987): 81-90. Link to SFX for this item
10. McCrae, R R R. "An introduction to the five-factor model and its applications." Journal of personality 60.2 (1992): 175-215. Link to Full Text for this item Link to SFX for this item
11. Smith, D J L. "The neuropharmacology of ADHD drugs in vivo: Insights on efficacy and safety." Neuropharmacology In Press, Uncorrected Proof.7/8 (2009): 608-618. Link to SFX for this item
12. Berman, S M. "Potential adverse effects of amphetamine treatment on brain and behavior: a review.(Drug overview)." Molecular psychiatry 14.2 (2009): 123-. Link to Full Text for this item Link to SFX for this item
13. Ozer, Daniel J. "PERSONALITY AND THE PREDICTION OF CONSEQUENTIAL OUTCOMES." Annual review of psychology 57.1 (2006): 401-421. Link to Full Text for this item Link to SFX for this item
14. Howard, Matt C. "Does the courage measure really measure courage? A theoretical and empirical evaluation." The journal of positive psychology 9.5 (2014): 449-459. Link to SFX for this item
15. McCrae, R R R. "Personality Trait Structure as a Human Universal." American psychologist 52.5 (1997): 509-516. Link to SFX for this item
16. Swami, V. "An examination of the factorial and convergent validity of four measures of conspiracist ideation, with recommendations for researchers." PLoS One 12.2 (2017). Link to Full Text for this item Link to SFX for this item
17. "Conspiracist ideation in Britain and Austria: Evidence of a monological belief system and associations between individual psychological differences and real-world and fictitious conspiracy theories." Journal of occupational and organizational psychology. 102.3: 443-463. Link to SFX for this item
18. Kollins, Scott H H. "ADHD, Substance Use Disorders, and Psychostimulant Treatment: Current Literature and Treatment Guidelines." Journal of attention disorders 12.2 (2008): 115-125. Link to Full Text for this item Link to SFX for this item
19. Vitiello, B. "Understanding the risk of using medications for attention deficit hyperactivity disorder with respect to physical growth and cardiovascular function." Child and adolescent psychiatric clinics of North America 17.2 (2008): 459-474. Link to SFX for this item
20. Harris, S. "Quantitative Drug Levels in Stimulant Psychosis: Relationship to Symptom Severity, Catecholamines and Hyperkinesia." The American journal on addictions 13.5 (2004): 461-470. Link to Full Text for this item Link to SFX for this item
View More...
View Less...
Select All Clear All

Expand list of advanced services Advanced